Aquaculture Shrimp Disease Welfare

Disease is a major welfare and production challenge in shrimp aquaculture. Intensive farming conditions create disease vulnerability that causes mass mortality and individual suffering.

Key Facts

White spot syndrome, early mortality syndrome, and other diseases cause enormous losses in shrimp aquaculture annually
High stocking densities create conditions that facilitate pathogen transmission and immune suppression
Routine antibiotic use in some shrimp production regions raises antimicrobial resistance concerns
Specific Pathogen Free (SPF) shrimp broodstock and biosecure hatcheries reduce but do not eliminate disease burden
Probiotics and water quality management can reduce disease incidence without antibiotic dependence
Disease outbreaks cause mass mortality events where large numbers of shrimp die from infection simultaneously

Welfare Considerations

Shrimp disease in intensive aquaculture represents a welfare problem amplified by production system design. The high-density conditions that make intensive shrimp farming economically viable simultaneously create environments where pathogens spread rapidly and individual shrimp immune systems are chronically stressed. Disease outbreaks cause mass mortality through infection processes that, given what we know about crustacean sentience, may involve suffering at scale. The antimicrobial dependence of some shrimp production regions creates additional welfare concerns: antibiotic-resistant infections are harder to treat, leading to extended suffering before mortality. Welfare-improving reforms — lower stocking densities, better biosecurity, probiotic management, and reduced antibiotic dependence — align with both welfare and long-term production sustainability goals.

What You Can Do

Support shrimp welfare certification standards that address stocking density and disease management practices
Choose shrimp products certified to antibiotic-free or responsible antibiotic use standards
Engage with retailers about their shrimp sourcing requirements for disease management and antibiotic use
Support research into low-density, biosecure shrimp production systems that reduce disease burden
Reduce shrimp consumption when welfare-certified, low-antibiotic options are unavailable
Advocate for international standards limiting antibiotic use in shrimp aquaculture to reduce resistance development